Bottom line
RYHEX vs XLV: the short answer
RYHEX (Health Care Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds.
But RYHEX is far broader, holding 135 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.
XLV is cheaper at 0.08% vs 1.64% — a difference of $156 a year per $10,000 invested.
Over five years, XLV returned +8.1% a year vs +3.9% for RYHEX.
RYHEX has a front-end sales load of up to 4.75%; the other does not.
Updated Nov 19, 2026
RYHEX vs XLV side by side
| RYHEX | XLV | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Guggenheim | SPDR (State Street) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.64% | 0.08% |
| Annual cost per $10k | $164 | $8 |
| 10-yr cost on $10k (prospectus) | $2,374 | $103 |
| Max front load | 4.75% | None |
| 12b-1 fee | 0.25% | 0.02% |
| 1-yr return | +8.7% | +14.5% |
| 5-yr return (annualized) | +3.9% | +8.1% |
| 10-yr return (annualized) | +7.1% | +9.8% |
| Best quarter | — | +14.5% |
| Worst quarter | — | −12.7% |
| Net assets (fund) | $19.4M | $40.6B |
| Number of holdings | 135 | 65 |
| Portfolio turnover | 244% | 2% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
23 of RYHEX's top 25 holdings also appear in XLV's top 25.
| Holding | RYHEX | XLV |
|---|---|---|
| Eli Lilly & Company | 3.63% | 16.51% |
| Johnson & Johnson | 2.88% | 10.64% |
| Abbvie Inc | 2.52% | 7.74% |
| Unitedhealth Group Inc | 2.22% | 6.57% |
| Merck & Company Inc | 2.04% | 5.52% |
| Thermo Fisher Scientific Inc | 1.61% | 3.24% |
| Amgen Inc | 1.56% | 3.40% |
| Abbott Laboratories | 1.42% | 2.75% |
| Gilead Sciences Inc | 1.39% | 2.73% |
| Vertex Pharmaceuticals Inc | 1.34% | 2.19% |
| Cvs Health Corp | 1.31% | 2.30% |
| Intuitive Surgical Inc | 1.31% | 2.45% |
| Danaher Corp | 1.30% | 2.09% |
| Pfizer Inc | 1.25% | 2.39% |
| Bristol-myers Squibb Company | 1.22% | 2.05% |
Source: SEC Form N-PORT
RYHEX top 10
- Eli Lilly & Company — 3.63%
- Johnson & Johnson — 2.88%
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Merck & Company Inc — 2.04%
- Thermo Fisher Scientific Inc — 1.61%
- Amgen Inc — 1.56%
- Abbott Laboratories — 1.42%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
FAQ
What is the difference between RYHEX and XLV?
Which is cheaper, RYHEX or XLV?
Should I own both RYHEX and XLV?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.